Oxalic Acid

Oxalic Acid

SCHEMBL6480142

O=C(O)C(=O)O.[O-][n+]1ccccc1Oc1ccc(C[C@H](CO)NC[C@@H](O)c2cccc(Cl)c2)cc1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 14/20 0.59
SLC2A1 P11166 3/20 0.52
ADRB2 P07550 9/20 0.51
ADRB1 P08588 9/20 0.51
CYP2D6 P10635 2/20 0.51
ADRA1D P25100 1/20 0.51
ADRA1A P35348 1/20 0.51
ADRA1B P35368 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
CYP3A4 P08684 1/20 0.48
HIF1A Q16665 1/20 0.48
GLA P06280 1/20 0.47
BACE1 P56817 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL6493584 0.80 ADRB3 (0.59) ADRB3SLC2A1ADRB2ADRB1CYP2D6
Oxalic Acid SCHEMBL6477691 0.78 ADRB3 (0.58) ADRB3SLC2A1ADRB2ADRB1CYP2D6
Oxalic Acid SCHEMBL6492423 0.78 ADRB3 (0.58) ADRB3SLC2A1ADRB2ADRB1CYP2D6
Oxalic Acid SCHEMBL6479546 0.78 ADRB3 (0.58) ADRB3SLC2A1ADRB2ADRB1CYP2D6
Oxalic Acid SCHEMBL6478099 0.77 ADRB3 (0.56) ADRB3SLC2A1ADRB2ADRB1CYP2D6
SCHEMBL6540539 0.76 ADRB3 (0.69) ADRB3SLC2A1ADRB2ADRB1CYP2D6
SCHEMBL6540533 0.76 ADRB3 (0.69) ADRB3SLC2A1ADRB2ADRB1CYP2D6
Oxalic Acid SCHEMBL6478738 0.76 ADRB3 (0.54) ADRB3SLC2A1ADRB2ADRB1CYP2D6
Hydrochloric Acid SCHEMBL6540803 0.76 ADRB3 (0.68) ADRB3SLC2A1ADRB2ADRB1CYP2D6
Hydrochloric Acid SCHEMBL6540807 0.76 ADRB3 (0.68) ADRB3SLC2A1ADRB2ADRB1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043358-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-02-24 US disclosed
US-20020143034-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2002-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020143034-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists ADRB1, ADRB2, ADRB3 ADRB3 3/4885SLC2A1 2925/4885ADRB2 2/4885
US-20050043358-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists ADRB2, ADRB1, ADRB3 ADRB3 3/4885SLC2A1 3066/4885ADRB2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.